188 related articles for article (PubMed ID: 38437852)
41. [Sjögren's Syndrome: Epidemiological, Diagnostic, Therapeutic and Evolutionary Aspects in the Aristide-Le-Dantec Teaching Hospital of Dakar, Senegal (2012-2016)].
Salissou GM; Moustapha N; Kaba C; Coumba D; Saïdou D
Bull Soc Pathol Exot; 2020; 113(3):136-142. PubMed ID: 33825393
[TBL] [Abstract][Full Text] [Related]
42. Systemic interferon type I and type II signatures in primary Sjögren's syndrome reveal differences in biological disease activity.
Bodewes ILA; Al-Ali S; van Helden-Meeuwsen CG; Maria NI; Tarn J; Lendrem DW; Schreurs MWJ; Steenwijk EC; van Daele PLA; Both T; Bowman SJ; Griffiths B; Ng WF; ; Versnel MA
Rheumatology (Oxford); 2018 May; 57(5):921-930. PubMed ID: 29474655
[TBL] [Abstract][Full Text] [Related]
43. Go Ask Your Patients! PSS-QoL Reported Perception of Dryness Correlates With Lacrimal and Salivary Flow in Primary Sjögren's Syndrome.
Lackner A; Bosch P; Zenz S; Horwath-Winter J; Rabensteiner DF; Hermann J; Graninger W; Stradner MH
Front Med (Lausanne); 2021; 8():660580. PubMed ID: 33937295
[No Abstract] [Full Text] [Related]
44. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
45. Burden of illness among subgroups of patients with primary Sjögren's syndrome and systemic involvement.
Gairy K; Knight C; Anthony P; Hoskin B
Rheumatology (Oxford); 2021 Apr; 60(4):1871-1881. PubMed ID: 33147609
[TBL] [Abstract][Full Text] [Related]
46. Beyond dry eye: The greater extent of Sjögren's systemic disease symptoms, the impact of COVID-19 and perceptions towards telemedicine identified through a patient co-designed study.
Greenan E; Tynan G; Collins D; Murphy CC; Flood M; Ní Gabhann-Dromgoole J
Health Expect; 2023 Dec; 26(6):2252-2263. PubMed ID: 37470291
[TBL] [Abstract][Full Text] [Related]
47. Primary Sjögren's syndrome: Longitudinal real-world, observational data on health-related quality of life.
Tarn J; Lendrem D; McMeekin P; Lendrem C; Hargreaves B; Ng WF
J Intern Med; 2022 Jun; 291(6):849-855. PubMed ID: 35018685
[TBL] [Abstract][Full Text] [Related]
48. The EULAR Sjögren's Syndrome Patient-Reported Index is an independent determinant of health-related utility values of Korean patients with primary Sjögren's syndrome.
Lee J; Koh JH; Kwok SK; Park SH
Clin Exp Rheumatol; 2016; 34(4):663-7. PubMed ID: 27050672
[TBL] [Abstract][Full Text] [Related]
49. Brief Report: Monoclonal Gammopathy and Risk of Lymphoma and Multiple Myeloma in Patients With Primary Sjögren's Syndrome.
Tomi AL; Belkhir R; Nocturne G; Desmoulins F; Berge E; Pavy S; Miceli-Richard C; Mariette X; Seror R
Arthritis Rheumatol; 2016 May; 68(5):1245-50. PubMed ID: 26636425
[TBL] [Abstract][Full Text] [Related]
50. Transcultural adaptation of the "EULAR Sjögren's Syndrome Disease Activity Index (ESSDAI)" into Brazilian Portuguese.
Serrano EV; Valim V; Miyamoto ST; Giovelli RA; Paganotti MA; Cadê NV
Rev Bras Reumatol; 2013; 53(6):483-93. PubMed ID: 24477727
[TBL] [Abstract][Full Text] [Related]
51. Sjögren's syndrome with and without neurological involvement.
Seeliger T; Kramer E; Konen FF; Zehrfeld N; Beider S; Prenzler NK; Gödecke V; Witte T; Skripuletz T; Ernst D
J Neurol; 2023 Jun; 270(6):2987-2996. PubMed ID: 36802030
[TBL] [Abstract][Full Text] [Related]
52. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
53. A single-center study of clinical features of pediatric Sjögren's syndrome.
Hou L; Wang N; Zhao C; Wang X; Du Y
Pediatr Rheumatol Online J; 2023 Oct; 21(1):119. PubMed ID: 37833819
[TBL] [Abstract][Full Text] [Related]
54. Effectiveness and safety of abatacept for the treatment of patients with primary Sjögren's syndrome.
Machado AC; Dos Santos LC; Fidelix T; Lekwitch I; Soares SB; Gasparini AF; Augusto JV; Junior NC; Trevisani VFM
Clin Rheumatol; 2020 Jan; 39(1):243-248. PubMed ID: 31420813
[TBL] [Abstract][Full Text] [Related]
55. Abatacept treatment reduces disease activity in early primary Sjögren's syndrome (open-label proof of concept ASAP study).
Meiners PM; Vissink A; Kroese FG; Spijkervet FK; Smitt-Kamminga NS; Abdulahad WH; Bulthuis-Kuiper J; Brouwer E; Arends S; Bootsma H
Ann Rheum Dis; 2014 Jul; 73(7):1393-6. PubMed ID: 24473674
[TBL] [Abstract][Full Text] [Related]
56. Association of immunological features with clinical manifestations in primary Sjogren's syndrome: a single-center cross-sectional study.
Relangi HSK; Naidu GSRSNK; Sharma V; Kumar M; Dhir V; Sharma SK; Sharma A; Minz RW; Jain S
Clin Exp Med; 2022 Nov; 22(4):613-620. PubMed ID: 34762228
[TBL] [Abstract][Full Text] [Related]
57. Articular and Peripheral Nervous System Involvement Are Linked to the Long-Term Outcome in Primary Sjögren's Syndrome: The Relevance of Single Organ Manifestations Rather Than a Composite Score as Predictors.
Quartuccio L; Gandolfo S; Zabotti A; Zandonella Callegher S; Fabro C; De Vita S
Front Immunol; 2019; 10():1527. PubMed ID: 31354708
[No Abstract] [Full Text] [Related]
58. Severe intestinal dysbiosis is prevalent in primary Sjögren's syndrome and is associated with systemic disease activity.
Mandl T; Marsal J; Olsson P; Ohlsson B; Andréasson K
Arthritis Res Ther; 2017 Oct; 19(1):237. PubMed ID: 29065905
[TBL] [Abstract][Full Text] [Related]
59. Comorbidities in the UK Primary Sjögren's Syndrome Registry.
Tarn J; Lendrem D; Barnes M; Casement J; Ng WF
Front Immunol; 2022; 13():864448. PubMed ID: 35603172
[TBL] [Abstract][Full Text] [Related]
60. Validation and adaptation to Spanish of the EULAR Sjögren's Syndrome Patient Reported Index (ESSPRI).
Posso-Osorio I; Nieto-Aristizábal I; Soto D; Ariza C; Urbano M; Cañas CA; Echeverri A; Castillo A; Tobón GJ
Reumatol Clin (Engl Ed); 2021; 17(7):388-391. PubMed ID: 34301381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
